The Effects of Social Support and Oxytocin Administration on Physiological Stress Reactivity in Essential Hypertension
Sponsor: Insel Gruppe AG, University Hospital Bern
Terminated
PI moved away from Bern; lack of personnel in Bern to conduct the study within a reasonable time frame.
Other terminated trials from Insel Gruppe AG, University Hospital Bern
- Cerebral Vasospasm · Phase NA · Jan 2026
- Arrhythmia Burden in Patients With Recurrent, Paroxysmal Atrial Fibrillation Despite Durable Pulmonary Vein Isolation · Sep 2025
- Head and Neck Cancer · Phase NA · May 2025
- Bariatric Surgery · Phase PHASE4 · Feb 2025
- Diet, Healthy · Phase NA · Nov 2024
See all terminations from Insel Gruppe AG, University Hospital Bern
Other Essential Hypertension trials with similar outcome
Listed as NCT01938911, this NA trial focuses on Essential Hypertension and remains terminated or withdrawn. Sponsored by Insel Gruppe AG, University Hospital Bern, it has been updated 9 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jul 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Feb 2019 — Nov 2020 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Suspended NA
-
Jan 2017 — Jun 2018 [monthly]
Suspended NA
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Insel Gruppe AG, University Hospital Bern
- University of Bern
For direct contact, visit the study record on ClinicalTrials.gov .